Is HRMY options pricing rich or cheap right now?

As of Jun 30, 2026, Harmony Biosciences Holdings, Inc. (HRMY) ATM IV is 75.3% against 20-day realized volatility of 36.7%. IV rank is 45.4%. HRMY options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 38.6 vol points.

What is the HRMY variance risk premium?

The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. HRMY is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.

What does HRMY IV rank mean for strategy selection?

IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. HRMY's current rank of 45.4% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.

Harmony Biosciences Holdings, Inc. (HRMY) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Harmony Biosciences Holdings, Inc. (HRMY) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.05B, listed on NASDAQ, employing roughly 268 people, carrying a beta of 0.97 to the broader market. Harmony Biosciences Holdings, Inc. Led by Jeffrey Dayno, public since 2020-08-19.

Snapshot as of Jun 30, 2026.

Spot Price: $36.23
ATM IV: 75.3%
HV 20-Day: 36.7%
HV 60-Day: 33.9%
IV Rank: 45.4%
IV Percentile: 72.2%

As of Jun 30, 2026, Harmony Biosciences Holdings, Inc. (HRMY) ATM implied volatility is 75.3%. 20-day realized volatility is 36.7%, producing an IV-HV spread of +38.6 vol points. Options are pricing in more volatility than the stock has recently delivered, the volatility risk premium. IV rank is 45.4%.

How HRMY iv/hv history Data Feeds Strategy Selection

Strategy selection on Harmony Biosciences Holdings, Inc. options does not derive from any single metric in isolation. The iv/hv history view above sits inside a broader read: ATM IV currently sits at 75.3% and dealer gamma exposure is positive, so dealer hedging is mechanically mean-reverting. Combine the iv/hv history data here with the volatility-skew surface, dealer-gamma exposure, max-pain level, and upcoming-events calendar to build a positioning thesis. Risk-defined structures (credit spreads, debit spreads, iron condors) are usually safer than naked positions while the regime is uncertain; the data on this page anchors the inputs but does not by itself constitute a trade thesis.

How to read the HRMY IV vs HV chart

The dual-line chart above tracks ATM implied volatility (forward-looking, what the chain is pricing) against 20-day realized historical volatility (backward-looking, what actually happened). ATM IV currently prints at 75.3%, 45.4% IV rank, against 36.7% realized over the trailing 20 trading days. Implied is pricing above realized by 38.6 vol points, the typical variance-risk-premium positive state in which premium sellers earn the gap. Persistent IV-above-HV is the variance-risk-premium-positive state typical of equity markets; persistent IV-below-HV is rare and usually marks underpriced vol that often expands.

HRMY IV/HV regimes and trade selection

HRMY IV rank at 45.4% sits mid-range - no structural edge from rank alone. Strategy choice should follow event calendar and the dealer-positioning read.

Using HRMY vol history alongside the term structure

The IV/HV gap on this page captures the level of premium; the term-structure slope on the volatility page captures its shape across expirations. Term structure is roughly flat at -0.013, no strong near vs far premium being priced. Pair the rank read with the slope read with the event calendar to choose the right tenor for the structure.

HRMY IV/HV signal in volatility-cycle context

Equity-vol cycles tend to compress and expand on multi-month timeframes: a typical sequence runs low-IV-rank consolidation (months of flat tape, decaying premium) into a vol-expansion catalyst (earnings miss, macro shock, regime change) into elevated-IV-rank stress (premiums fat, dispersion high) back to mean-reverting compression. HRMY's 45.4% IV rank places the ticker in the mid-range of its 1-year window - no strong cycle-position signal. The ratio of HV-20 (36.7%) to HV-60 (33.9%) gives a second cycle indicator: when 20-day exceeds 60-day, recent realization is running hotter than the trailing-quarter average - typically a sign that recent days have already started expanding vol regardless of where IV rank prints. Use the time series above to spot inflection points: meaningful IV/HV gap closures and openings tend to precede regime shifts by a few sessions.

Learn how implied vs realized volatility is reported and how to read the data →

Daily ATM implied volatility and 20-day realized (historical) volatility for HRMY over the last ~41 trading days. The IV-HV gap measures the variance risk premium - when IV trades persistently above realized HV, premium-sellers earn the spread; when IV dips below HV, vol is structurally underpriced.

Daily values from end-of-day option_ticker_snapshots. Series sparse on illiquid tickers reflects gaps in the upstream end-of-day options data feed.

Most recent 15 trading days (descending). Older history appears in the chart above.

Date	ATM IV	HV 20d	HV 60d	IV Rank
Jun 30, 2026	75.3%	36.7%	33.9%	45.4%
Jun 29, 2026	84.8%	36.0%	33.7%	54.3%
Jun 26, 2026	76.9%	36.0%	33.7%	46.9%
Jun 25, 2026	67.1%	34.8%	33.7%	37.7%
Jun 24, 2026	67.6%	33.1%	33.2%	38.2%
Jun 23, 2026	62.9%	32.9%	33.8%	33.8%
Jun 22, 2026	65.6%	33.5%	33.8%	36.3%
Jun 18, 2026	74.3%	35.3%	33.8%	44.5%
Jun 17, 2026	61.9%	36.7%	34.2%	32.9%
Jun 16, 2026	61.9%	36.6%	34.1%	32.9%
Jun 15, 2026	70.2%	36.2%	34.0%	40.6%
Jun 12, 2026	63.8%	37.0%	34.2%	34.6%
Jun 11, 2026	73.6%	35.8%	33.9%	43.8%
Jun 10, 2026	69.9%	35.6%	33.9%	40.4%
Jun 9, 2026	80.1%	33.3%	33.0%	49.9%

Frequently asked HRMY iv/hv history questions

Is HRMY options pricing rich or cheap right now?: As of Jun 30, 2026, Harmony Biosciences Holdings, Inc. (HRMY) ATM IV is 75.3% against 20-day realized volatility of 36.7%. IV rank is 45.4%. HRMY options are pricing in more volatility than the stock has recently realized: a positive variance risk premium worth 38.6 vol points.
What is the HRMY variance risk premium?: The variance risk premium is the persistent gap between implied and subsequently realized volatility. In equity markets it averages positive because option sellers demand compensation for bearing variance shocks. HRMY is currently priced consistently with this premium, which is one input to whether short-vol or long-vol structures carry their typical edge.
What does HRMY IV rank mean for strategy selection?: IV rank normalizes the current ATM IV to its 1-year range: 0% is the low, 100% is the high. HRMY's current rank of 45.4% signals where current pricing sits in its own 1-year history. High-rank regimes typically favor premium-selling structures (credit spreads, condors, covered calls); low-rank regimes typically favor premium-buying or long-volatility structures.